Pharmacology of novel steroidal inhibitors of cytochrome P45017 (17α-hydroxylase/C17–20 lyase)
- 1 September 1994
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 50 (5-6) , 267-273
- https://doi.org/10.1016/0960-0760(94)90131-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- 4-pregnene-3-one-20β-carboxaldehyde: A potent inhibitor of 17α-hydroxylase/C17,20-lyase and of 5α-reductaseThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- The effect of the aromatase inhibitor, rogletimide (pyridoglutethimide), on guinea pig adrenal cell steroidogenesis and placental microsomal aromatase activity: Comparison with aminoglutethimide and CGS 16949AThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- 17β-(Cyclopropylamino)-androst-5-en-3β-ol, a selective mechanism-based inhibitor of cytochrome P45017α (steroid 17α-hydroxylase/C17–20 lyase)Biochemical and Biophysical Research Communications, 1989
- Ketoconazole as Primary Treatment of Prostatic CancerBritish Journal of Urology, 1988
- Hepatic reactions associated with ketoconazole in the United Kingdom.BMJ, 1987
- Effect of ketoconazole (an imidazole antimycotic agent) and other inhibitors of steroidogenesis on cytochrome P450-catalyzed reactionsJournal of Steroid Biochemistry, 1986
- Ketoconazole Therapy in Advanced Prostatic CancerJournal of Urology, 1984
- Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes.Journal of Clinical Investigation, 1983
- Fluctuations in Plasma Testosterone Levels in Adult Male Rats and MiceEndocrinology, 1973